Notes from the Field: Acquisition of Delamanid Under a Compassionate Use Program for Extensively Drug-Resistant Tuberculosis — United States, 2017
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i


Notes from the Field: Acquisition of Delamanid Under a Compassionate Use Program for Extensively Drug-Resistant Tuberculosis — United States, 2017
Filetype[PDF-131.78 KB]


No Related Documents.

You May Also Like:

  1. Personal Author:
    Maryandyshev, Andrey ; Pontali, Emanuele ; ...
    Published Date:
    Oct 17 2017
    Source:
    Emerg Infect Dis. 23(10):1718-1721.
    Description:
    We report the experiences of 5 patients taking bedaquiline with delamanid in combination: 1 patient was cured; 3 culture converted, with 2 continuing ...
    File Type:
    Filetype[PDF - 997.61 KB]
    File Type:
    Filetype[PDF - 997.61 KB]
  2. Personal Author:
    D’Ambrosio, Lia ; Centis, Rosella ; ...
    Published Date:
    Nov 29 2012
    Source:
    N Engl J Med. 367(22):2154-2156.
    File Type:
    Filetype[PDF - 32.34 KB]
    File Type:
    Filetype[PDF - 32.34 KB]
  3. Personal Author:
    Sharma, Aditya ; Hill, Andrew ; ...
    Corporate Authors:
    for the Global Preserving Effective TB Treatment Study Investigators
    Published Date:
    May 09 2017
    Source:
    Lancet Infect Dis. 17(7):707-715.
    Description:
    BackgroundMultidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis are emerging worldwide. The Green Light Committee initiative sup...
    File Type:
    Filetype[PDF - 1.27 MB]
    File Type:
    Filetype[PDF - 1.27 MB]
  4. Personal Author:
    Martinson, Neil A. ; Chaisson, Richard E. ;
    Published Date:
    Jun 1 2011
    Source:
    J Acquir Immune Defic Syndr. 57(2):89-91.
    File Type:
    Filetype[PDF - 30.84 KB]
    File Type:
    Filetype[PDF - 30.84 KB]
  5. Personal Author:
    Mondal, Rajesh ; Jain, Amita ;
    Published Date:
    Sep 2007
    Source:
    Emerg Infect Dis. 13(9):1429-1431.
    File Type:
    Filetype[PDF - 96.69 KB]
    File Type:
    Filetype[PDF - 96.69 KB]